Browsing Over 990 Presentations

Sort By
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC ESMO Colloquium

Introduction

Lecture Time
12:45 PM - 12:50 PM
Session Name
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
Speakers
  • Ross A. Soo
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
  • Ross A. Soo

Navigating the waters of ES-SCLC (ID 1781)

Q&A (ID 1787)

Presentation of real world outcomes in ER+ HER2- mBC (ID 1792)

Generating meaningful evidence with novel trial designs and real-world data (ID 1797)

The landscape and role of IO-Chemo combination in NSCLC treatment (ID 1802)

ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC ESMO Colloquium

EGFR mutant mNSCLC: Single agent or in combination?

Lecture Time
01:15 PM - 01:40 PM
Session Name
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
Speakers
  • Fabrice Barlesi
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
  • Fabrice Barlesi

Introduction (ID 1779)

PARPi maintenance: A new paradigm in the management of frontline ovarian cancer (ID 1784)

From clinical trials to practice: Changing the trajectory for metastatic breast cancer patients (ID 1790)

Introduction (ID 1795)

Recent advances in metastatic prostate cancer management (ID 1881)